Hepatocellular carcinoma diagnosis and treatment /

Por Carr, Brian I.
Publicado em c200

Hepatic Artery Chemoembolization for Hepatocellular Carcinoma Recurrence Confined to the Transplanted Liver

Por Carr, Brian I.
Publicado em 2012

Review of therapies for intermediate and advanced stage hepatocellular carcinoma, not suitable for curative therapies: a rapidly changing landscape

Por Carr, Brian I.
Publicado no Hepatoma Res (2019)

Psychological aspects of cancer a guide to emotional and psychological consequences of cancer, their causes and their management /

Por Carr, Brian I., Steel, Jennifer
Publicado em c201

Thrombocytosis and Hepatocellular Carcinoma

Por Carr, Brian I., Guerra, Vito
Publicado em 2013

HCC size: platelets, gamma glutamyl transpeptidase and alkaline phosphatase

Por Carr, Brian I., Guerra, Vito
Publicado em 2013

Macro- and micro-environmental factors in clinical HCC

Por Pancoska, Petr, Carr, Brian I.
Publicado em 2014

Critical Role of Extracellular Signal‐regulated Kinase (ERK) Phosphorylation in Novel Vitamin K Analog‐induced Cell Death

Por Osada, Shinji, Carr, Brian I.
Publicado no Jpn J Cancer Res (2000)

Sorafenib combined vitamin k induces apoptosis in human pancreatic cancer cell lines through RAF/MEK/ERK and c-Jun NH2-terminal kinase pathways

Por Wei, Gang, Wang, Meifang, Carr, Brian I.
Publicado em 2010

Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study

Por Carr, Brian I., Pancoska, Petr, Branch, Robert A.
Publicado em 2009

Phenotypic Categorization and Profiles of Small and Large Hepatocellular Carcinomas

Por Pancoska, Petr, Lu, Sheng-Nan, Carr, Brian I
Publicado em 2013

GROWTH INHIBITORY ACTIONS OF PROTHROMBIN ON NORMAL HEPATOCYTES: INFLUENCE OF MATRIX

Por Carr, Brian I., Kar, Siddhartha, Wang, Meifang, Wang, Ziqiu
Publicado em 2007

Platelet-related phenotypic patterns in hepatocellular carcinoma patients

Por Carr, Brian I., Lin, Chih-Yun, Lu, Sheng-Nan
Publicado em 2014

Evaluation of total HCC lifespan, including both clinically evident and pre-clinical development, using combined Network Phenotyping Strategy and Fisher information analysis

Por Pančoška, Petr, Skála, Lubomír, Nešetřil, Jaroslav, Carr, Brian I.
Publicado no Semin Oncol (2015)

Gender-based outcomes differences in unresectable hepatocellular carcinoma

Por Buch, Shama C., Kondragunta, Venkateswarlu, Branch, Robert A., Carr, Brian I.
Publicado em 2007

Therapeutic equivalence in survival for hepatic arterial chemoembolization and (90)Yttrium microspheres (Y90) treatments in unresectable hepatocellular carcinoma: a 2 cohort study

Por Carr, Brian I., Kondragunta, Venkateswarlu, Buch, Shama C., Branch, Robert A.
Publicado em 2010

Vitamin K enhancement of Sorafenib-mediated HCC cell growth inhibition in vitro and in vivo

Por Wei, Gang, Wang, Meifanf, Hyslop, Terry, Wang, Ziqiu, Carr, Brian I.
Publicado em 2010

Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization

Por Ventura, Yossi, Carr, Brian I, Kori, Issac, Guerra, Vito, Shibolet, Oren
Publicado no World J Gastroenterol (2018)

Regional Cancer Chemotherapy for Advanced Stage Hepatocellular Carcinoma

Por Carr, Brian I., Iwatsuki, Shunzaburo, Starzl, Thomas E., Selby, Rick, Madariaga, Juan
Publicado em 1993

Radiation Therapy for Primary Carcinoma of the Extrahepatic Biliary System: An Analysis of 63 Cases

Por Flickinger, John C., Epstein, Alan H., Iwatsuki, Shunzaburo, Carr, Brian I., Starzl, Thomas E.
Publicado em 1991